ArticleFrontiers in oncology2021

Prospective Exploratory Analysis of Angiogenic Biomarkers in Peripheral Blood in Advanced NSCLC Patients Treated With Bevacizumab Plus Chemotherapy: The ANGIOMET Study.

Eloisa Jantus-Lewintre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.